Patent information
IP India · live recordApplication number
202517046441
Filing date
14 May 2025
Status
Application Awaiting Examination
Publication number
31/2025
Publication type
INA
Invention field
Chemical
Abstract
The present invention discloses an ophthalmic formulation/composition comprising cinnamic acids or their derivatives catechins or its derivatives either alone or in combination thereof together with acceptable excipients for treating/clearing/reducing conditions associated with cataract intraocular pressure and glaucoma lenticular degeneration corneal epithelial proliferation and liquefaction and inflammation.
Applicants
1India
FERTIS INDIA PVT LTD
6 3 668/10/56 Plot No 56 Ist Floor
Durga Nagar Colony Punjagutta
Hyderabad Telangana 500082
Inventors
3India
KANUMURU Rahul RajuFertis India Pvt Ltd
6 3 668/10 56 First floor Plot no:56
Durga nagar colony Punjagutta
Hyderabad Telangana 500082
India
KOCHUMALAYIL Shaji GeorgeFertis India Pvt Ltd
6 3 668/10 56 First floor Plot no:56 Durga nagar colony Punjagutta
Hyderabad Telangana 500082
India
SURANENI RavikumarFertis India Pvt Ltd
6 3 668/10 56 First floor Plot no:56
Street Durga nagar colony Punjagutta
Hyderabad Telangana 500082
Documents
Sign in to openApplication documents
1
202517046441-STATEMENT OF UNDERTAKING (FORM 3) [14-05-2025(online)].pdf
14 May 2025
2
202517046441-REQUEST FOR EXAMINATION (FORM-18) [14-05-2025(online)].pdf
14 May 2025
3
202517046441-FORM 18 [14-05-2025(online)].pdf
14 May 2025
4
202517046441-FORM 1 [14-05-2025(online)].pdf
14 May 2025
5
202517046441-DRAWINGS [14-05-2025(online)].pdf
14 May 2025
6
202517046441-DECLARATION OF INVENTORSHIP (FORM 5) [14-05-2025(online)].pdf
14 May 2025
7
202517046441-COMPLETE SPECIFICATION [14-05-2025(online)].pdf
14 May 2025
8
202517046441-FORM-26 [17-07-2025(online)].pdf
17 Jul 2025
9
202517046441-GPA-010825.pdf
05 Aug 2025
10
202517046441-Correspondence-010825.pdf
05 Aug 2025
11
202517046441-Proof of Right [30-10-2025(online)].pdf
30 Oct 2025
12
202517046441-FORM 3 [10-11-2025(online)].pdf
10 Nov 2025